Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
119,654,959
-
Share change
-
-13,407,340
-
Total reported value
-
$28,425,215,078
-
Put/Call ratio
-
53%
-
Price per share
-
$237.65
-
Number of holders
-
477
-
Value change
-
-$3,086,850,614
-
Number of buys
-
241
-
Number of sells
-
224
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2022
As of 31 Dec 2022,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
477 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
119,654,959 shares.
The largest 10 holders included
Capital World Investors, FMR LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Dodge & Cox, PRICE T ROWE ASSOCIATES INC /MD/, T. Rowe Price Investment Management, Inc., and JPMORGAN CHASE & CO.
This page lists
477
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.